Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Stopped The study was closed early due to low enrollment and new information regarding the benefit of the study regimen.

Conditions

• Colorectal Neoplasms

Interventions

• DRUG: Bevacizumab
• DRUG: Oxaliplatin
• DRUG: Capecitabine
• DRUG: Irinotecan

Sponsor

NSABP Foundation Inc

Collaborators

• [object Object]
• [object Object]
• [object Object]